Associated Papers
Leveraging genomic diagnostics for prognostics and therapeutics in pediatric acute leukemia.
Newman H et al.
Hemasphere, 2025
41306327 (PubMed )
Supplement: HEM3-9-e70269-s013.xlsx › Supplemental_Table_5_-_SSVs
Alternative driver pathways in peripheral nerve sheath tumors - including DICER1 and/or KRAS alterations.
Chang HY et al.
The Journal of Pathology, 2025
Endogenous oncogenic KRAS expression increases cell proliferation and motility in near-diploid hTERT RPE-1 cells.
Hindul NL et al.
The Journal of Biological Chemistry, 2024
RAS-MAPK Pathway Mutations in Congenital Pulmonary Airway Malformations.
Windrich J et al.
American Journal of Respiratory and Critical Care Medicine, 2024
Custom multi‑tumor next‑generation sequencing panel for routine molecular diagnosis of solid tumors: Validation and results from three‑year clinical use.
Chevrier S et al.
International Journal of Molecular Medicine, 2022
35244186 (PubMed )
Supplement: Supplementary_Data2.xlsx › Feuil1
Clinical application of a cancer genomic profiling assay to guide precision medicine decisions.
Eifert C et al.
Personalized Medicine, 2017
28890729 (PubMed )
Supplement: pme-14-309-s2.pdf
QIAGEN Therascreen KRAS RGQ Assay, QIAGEN KRAS Pyro Assay, and Dideoxy Sequencing for Clinical Laboratory Analysis of KRAS Mutations in Tumor Specimens.
Alqahtani QM et al.
Laboratory Medicine, 2016
Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer.
Vaughn CP et al.
Genes, Chromosomes & Cancer, 2011
Select a paper to view details